Pharmaceutical Testing Jobs in Missouri (NOW HIRING)

In over just 30 years, Eurofins has grown from one laboratory in Nantes, France to over 47,000 staff across a network of more than 950 independent companies in over 57 countries and operating more than 950 laboratories. Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing.

 In 2026, Eurofins generated total revenues of EUR 4.56 billion, and has been among the best performing stocks in Europe over the past 20 year

The President of Eurofins BioPharma Product Testing (BPT) Columbia is responsible for leading one of the largest and most successful BioPharma testing operations within the Eurofins network. This executive serves as the chief business leader for the site, with full accountability for growth, profitability, operational excellence, customer satisfaction, quality, compliance, employee engagement, and long-term strategic development.

The ideal candidate is a growth-oriented life sciences executive who combines strong commercial acumen, operational excellence, financial discipline, technological innovation, and people-centered leadership. This leader will guide the next phase of expansion while preserving the entrepreneurial culture, high employee engagement, and operational excellence that have fueled Columbia's growth.

The successful candidate will embody the Eurofins Mission and Values by contributing to a safer and healthier world through innovative, high-quality laboratory services while creating opportunities for employees and generating sustainable shareholder value. Eurofins' core values include Customer Focus, Quality, Competence & Team Spirit, and Integrity.

Scope of Responsibility

Business Scale

• Annual Revenue: Approximately $75 million
• Employees: Approximately 350
• Full site P&L Responsibility
• One of the largest BioPharma Product Testing operations within Eurofins North America
• Significant contributor to Eurofins' pharmaceutical testing strategy and growth

Service Portfolio

Responsible for a comprehensive range of pharmaceutical development and GMP testing services including:

• Analytical testing
• Method development
• Method validation
• Stability studies
• Cell and molecular biology services
• Synthesis with radioactive labeling
• Pharmaceutical product development support
• Commercial release testing
• Regulatory support services

Strategic Responsibilities

• Long-term business planning and execution
• Revenue growth and profitability
• Customer diversification and risk management
• Capital planning and investment oversight
• Facility expansion planning
• Talent development and succession planning
• Operational excellence and productivity improvement
• Commercial strategy execution
• Global collaboration across the Eurofins network

Critical Success Factors

1. Commercial Growth and Customer Diversification

The next President must be a commercially focused business leader capable of partnering effectively with the North American commercial team to expand the customer portfolio and reduce concentration risk.

Key Objectives

• Maintain strong growth with the site's largest customer while reducing overall business dependence on any single client.
• Expand relationships with emerging biotechnology companies and mid-sized pharmaceutical organizations.
• Diversify revenue streams through expanded services and new market opportunities.
• Build executive-level relationships across the pharmaceutical and biotechnology industry.
• Drive sustainable organic growth while preserving profitability.
• Collaborate closely with business development teams to identify new opportunities and market trends.

Desired Experience

• Proven track record of commercial growth.
• Experience managing strategic client relationships.
• Success reducing customer concentration risk.
• Strong understanding of pharmaceutical outsourcing markets.
• Ability to balance customer retention with aggressive business development.

2. Operational Excellence, Automation, and AI

The future success of Columbia will require significant advancements in automation, digital transformation, and global service delivery models.

Key Objectives

• Evaluate and implement AI-enabled solutions across laboratory operations.
• Drive laboratory automation initiatives that improve productivity and scalability.
• Expand utilization of Eurofins India and other global resources to enhance efficiency and competitiveness.
• Continue maintaining industry-leading margins and financial performance.
• Improve productivity while protecting quality and compliance.
• Maintain a culture of continuous improvement and operational excellence.
• Utilize data and business intelligence to support decision-making.

Desired Experience

• Operational Excellence leadership.
• Lean or Six Sigma experience.
• Digital transformation leadership.
• AI and automation implementation.
• Global resource management.
• Continuous improvement methodologies.

3. Capacity Expansion and Infrastructure Development

The next President will lead the site's next major phase of physical growth.

Key Objectives

• Develop and execute long-term facility expansion plans.
• Evaluate and lead the purchase of the current facility.
• Oversee design and implementation of future building expansions.
• Successfully implement second-shift operations.
• Ensure infrastructure supports sustained growth.
• Drive effective capital allocation decisions.
• Balance growth with operational efficiency and customer service.

Desired Experience

• Facility expansion projects.
• Capital investment management.
• Infrastructure planning.
• Scaling laboratory operations.
• Multi-site operational leadership.

4. Culture and Talent Leadership

One of Columbia's greatest strengths is its culture. The successful candidate must preserve and enhance this competitive advantage while continuing to create opportunities for employees.

Key Objectives

• Maintain a positive, high-performance culture.
• Create meaningful career opportunities for employees.
• Develop future leaders and succession pipelines.
• Foster strong employee engagement and retention.
• Promote collaboration and teamwork across all functions.
• Lead with transparency, accountability, and integrity.
• Ensure employees remain connected to the mission and values of Eurofins.

Leadership Expectations

The President should consistently model:

• Customer Focus
• Quality
• Competence & Team Spirit
• Integrity

while reinforcing Eurofins' mission of creating opportunities for employees, providing exceptional service to customers, and generating sustainable shareholder value.

Leadership Characteristics

The ideal candidate will be:

Strategic

Able to develop and execute a long-term vision for growth while managing near-term priorities.

Commercially Driven

Views customer diversification and business development as critical responsibilities.

Financially Disciplined

Understands how to balance growth, investment, productivity, and profitability.

Technology Forward

Embraces AI, automation, digital transformation, and innovation as competitive differentiators.

Operationally Excellent

Capable of driving efficiency improvements without compromising quality or culture.

People Focused

Invests in leaders, develops talent, and creates opportunities throughout the organization.

Culture Builder

Protects the entrepreneurial culture that has driven Columbia's success while preparing the organization for its next chapter of growth.

Preferred Candidate Background

The strongest candidates will likely possess experience in:

• BioPharma testing services
• CROs
• CDMOs
• Pharmaceutical manufacturing
• Contract laboratory services
• Life science service organizations

Demonstrated experience should include:

• Leading organizations of 100+ employees
• Full P&L responsibility with revenues $25M+
• Customer diversification initiatives
• AI and automation implementation
• Facility expansion projects
• Margin improvement programs
• Talent development and succession planning
• Regulated environments (FDA, GMP, GLP, ICH)

What Success Looks Like in 3-5 Years

The successful President will have:

• Reduced customer concentration risk while maintaining growth with the largest client
• Continued double-digit revenue growth
• Maintained industry-leading profitability and margins
• Successfully implemented AI and automation initiatives
• Expanded use of Eurofins India and other global capabilities
• Completed facility expansion and/or building acquisition initiatives
• Successfully implemented second-shift operations
• Built a strong leadership succession pipeline
• Maintained exceptional employee engagement and retention
• Strengthened Columbia's reputation as a flagship Eurofins BioPharma testing operation
• Continued creating opportunities for employees while delivering exceptional value to customers and shareholders in alignment with the Eurofins Mission and Values

In a fast growing group, successful leaders are frequently being offered increased areas of responsibility (subject to geographic mobility).
Eurofins offers international opportunities to strong performers.